Abstract The interaction of amyloid b-proteins (Abs) with membrane lipids has been postulated as an early event in Ab fibril formation in Alzheimer's disease. We evaluated the effects of several putative bioactive Abs and gangliosides on neural stem cells (NSCs) isolated from embryonic mouse brains or the subventricular zone of adult mouse brains. Incubation of the isolated NSCs with soluble Ab1-40 alone did not cause any change in the number of NSCs, but soluble Ab1-42 increased their number. Aggregated Ab1-40 and Ab1-42 increased the number of NSCs but soluble and aggregated Ab25-35 decreased the number. Soluble Ab1-40 and Ab1-42 did not affect the number of apoptotic cells but aggregated Ab1-40 and Ab1-42 did. When NSCs were treated with a combination of GM1 or GD3 and soluble Ab1-42, cell proliferation was enhanced, indicating that both GM1 and GD3 as well as Abs are involved in promoting cell proliferation and survival of NSCs. These observations suggest the potential of beneficial effects of using gangliosides and Abs for promoting NSC proliferation.
Introduction
Alzheimer's disease (AD) is the most common form of dementia with clinical symptoms that include deficits in memory, judgment, thinking, and behavior. Those symptoms usually develop slowly and become worse over time, interfere with daily tasks, and ultimately lead to death. It is well accepted that deposition of aggregated amyloid bprotein (Ab) to form amyloid plaques, also known as senile plaques (SPs), together with associated reactive astrocytosis and dystrophic neuritis, represent major pathological hallmarks of AD [1] . During neurodegeneration, the physicochemical properties of membranes are altered, which results in imbalances in the proportion of membranous lipids. Among the various lipid changes, the most notable are observed with gangliosides during the progression of AD [2] .
Gangliosides are sialic acid-containing glycosphingolipids expressed primarily in the outer leaflet of the plasma membrane of all vertebrate cells and are particularly abundant in the nervous system [3, 4] . The expression of neuronal gangliosides changes dramatically during cellular differentiation and brain development. For instance, in rodent brains a shift from the synthesis of simple gangliosides, such as GM3 and GD3, to the synthesis of the more complex gangliosides in the a-and b-series during brain development has been well documented [5, 6] . Remarkably, GD3 is predominant in embryonic brain, particularly in NSCs, and accounts for over 80 % of the total ganglioside species in those cells. On the other hand, the level of GM1 increases in mature brain and differentiated neural cells. Several reports have indicated that gangliosides can interact with Abs with high affinities [7, 8] , and that this interaction may result in conformational changes of Abs [8] [9] [10] . Histochemical analysis of amyloid plaques in the SPs of AD brains revealed the presence of the GM1-bound Abs, which may act as an endogenous seed for Ab fibrillogenesis [11] .
Unfortunately, at present there has not been any effective therapy to halt the progression of AD. Cognitive enhancers such as donepezil and memantine have been used [12] , but these drugs can only help to ameliorate the symptoms. With the advantage of cell replacement therapy, it is expected that the use of neural stem cells (NSCs) may contribute to the treatment of AD as well as several other neurodegenerative disorders. NSCs are undifferentiated neural cells characterized by their high proliferative potential and the capacity for self-renewal with retention of multipotency, i.e., generating brain-forming cells such as neurons, astrocytes, and oligodendrocytes. For the therapeutic use of NSCs in AD, detailed clarification of the effects of Abs and gangliosides on NSCs seems to be warranted. In this regard, it is worth noting that Abs have been reported to possess neurogenic effects on NSCs [13] [14] [15] [16] [17] . Nevertheless, the effects of Abs on NSCs are still controversial because Abs have also been reported to be cytotoxic in some other studies [18] [19] [20] [21] . This discrepancy may result from the difference of the patterns and levels of gangliosides expressed in the NSCs. In fact, we have recently reported that a combination of Ab1-40 and GM1 at relatively high concentrations (submillimolar) co-operatively exerted a cytotoxic effect on mouse embryonic NSCs [22] . Furthermore, the effects of other forms of Abs (e.g., Ab25-35 and Ab1-42) and gangliosides on NSCs have never been evaluated. In addition, the effects of the aggregated forms of Abs, which are known to be present in physiological conditions, with gangliosides on NSCs also have not been investigated. In this research, we carried out a systematic study to investigate the effects of various forms of Abs (Ab25-35, Ab1-40, and Ab1-42) and several representative gangliosides (GM1, GD3, and GM3) on mouse NSCs isolated from embryonic brains and the subventricular zone (SVZ) of adult brains.
Materials and Methods

Materials
GM1, GD3 and GM3 used in this study were isolated from either human brains or bovine buttermilk in our laboratory by established procedures [23] [24] [25] . Ab1-40, Ab1-42 and Ab25-35 were purchased from Bachem Americas (Torrance, CA). To prepare the aggregated forms of Abs, the peptide solutions were incubated at 37°C for 3 days before use [13, 14] .
Neural Stem Cell Culture
Mouse NSCs were prepared from embryonic brains or SVZ of adult brains in the form of neurospheres, which are floating clonal aggregates formed by NSCs in vitro [26] . In brief, single-cell suspensions prepared from the striata of embryonic mouse brains at E14.5 or the SVZ of adult mouse brains by trypsinization and mechanical trituration were cultured in Neurobasal A medium (Invitrogen, Carlsbad, CA) supplemented with B27 (Invitrogen), 20 ng/ ml of basic fibroblast growth factor (bFGF) (Peprotech, Rocky Hill, NJ), and 20 ng/ml of epidermal growth factor (EGF) (Peprotech). Neurospheres formed after 1 week were collected for passage or further analyses. The use of animals for this study was approved by the Institutional Animal Care and Use Committees at Georgia Regents University and Charlie Norwood Veterans Affairs Medical Center, Augusta, GA.
WST-8 Assay
The number of NSCs cultured in the presence or absence of gangliosides and/or Abs was estimated by the WST-8 assay using a Cell Counting Kit-8 (Dojindo, Kumamoto, Japan). For neurosphere experiments (Fig. 1) , NSCs dissociated from neurospheres were plated onto non-coated 96-well plates at a density of 1 9 10 4 cells per well. At the time the culture was started, gangliosides and Ab were dissolved in media. For monolayer culture of NSCs (Figs. 2, 3, 4 , and 5), the dissociated NSCs from neurospheres were plated onto 96-well plates that had been coated with poly-lornithine (Sigma-Aldrich, St. Louis, MO) and fibronectin (Sigma-Aldrich). On the next day, gangliosides and/or Ab dissolved in media were added to each well. The total volume of culture media was 100 ll/well. After 3 days of culture, a 10-ll WST-8 solution was added to each well.
After incubating 3 h in a CO 2 incubator, the absorbance of WST-8-formazan produced by the dehydrogenase activity in living neural cells was measured at a wavelength of 450 nm using a Benchmark Plus Microplate Spectrophotometer (Bio-Rad Laboratories, Hercules, CA). The absorbance measured by this assay was highly correlative with the number of living NSCs.
TUNEL Assay
Apoptotic cells were detected with the TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) assay as previously described [22, 26] . In brief, cells were plated onto chamber slides coated with poly-lornithine and fibronectin and cultured for 3 days in Neurobasal A medium containing Abs in the presence of 20 ng/ml of bFGF and 20 ng/ml of EGF. The cells were then fixed in PBS containing 4 % paraformaldehyde for 1 h at room temperature and permeabilized in 0.1 % sodium citrate containing 0.1 % Triton X-100 for 2 min at 4°C. The cells were incubated with the fluorescein-conjugated TUNEL reaction mixture (Roche Diagnostics, Mannheim, Germany) for 2 h at 37°C. Nuclei were stained with Hoechst 33258. The stained cells were photographed under a Nikon Eclipse TE300 fluorescent microscope equipped with a digital CCD camera.
Statistical Evaluation
Data are expressed as mean ± standard error of the mean (SEM) from three to nine independent experiments. Statistical significance was determined using unpaired twotailed Student's t test, and p \ 0.05 was regarded as significant.
Results
Effects of High Concentrations of Gangliosides on Neurospheres
Neurospheres were generated from dissociated cells from the striata of E14.5 embryos or SVZ of adult mice. To measure the cell numbers, the isolated cells from neurospheres were treated with gangliosides, and living cells were counted 3 days after culture. The relative absorbance of the WST-8 assay revealed the percentage of absorbance against vehicle treatment. Both GM1 and GD3 at higher concentrations (50 and 200 lM) significantly decreased the cell numbers in a dose-dependent manner (Fig. 1b) . Smaller neurospheres were observed (data not shown) after treatment with high concentrations of gangliosides. These results indicate that gangliosides GM1 and GD3 can exert an inhibitory effect on cell proliferation on neurospheres in a dose-dependent manner.
Effects of Abs on Neurospheres
Next, the cell numbers were counted after treatments with Abs on neurosphere preparations. Treatment with a soluble form of Ab1-42 (10 lM) significantly increased the number of cells of neurospheres prepared from both embryonic (116 ± 5 %) and adult (109 ± 3 %) brains (data not shown). Soluble Ab1-40 did not have any effect on the numbers of cells on neurospheres (data not shown).
On the other hand, the aggregated forms of Ab1-40 and Ab1-42 significantly increased the numbers of cells from neurospheres in a dose-dependent manner (Fig. 1c) . At high concentrations of Ab1-40 and Ab1-42 (50 lM), the numbers of cells were elevated to 235 ± 10 % for Ab1-40 and 170 ± 5 % for Ab1-42 of the normal growth rate of embryonic neurospheres, respectively. In the presence of aggregated forms of Abs, the neurospheres appeared larger (data not shown). Increases in the cell number were also found for adult neurospheres treated with the aggregated forms of Ab1-40 and Ab1-42 (data not shown). Under these conditions, the aggregated form of Ab25-35 exhibited inhibitory effects on the number of cells of neurospheres in a dose-dependent manner (Fig. 1c) .
Effects of High Concentration of Gangliosides and the Aggregated Forms of Abs on Neurospheres
The aggregated forms of Ab1-40 and Ab1-42 exhibited proliferative effects of the cells for embryonic and adult neurospheres, as shown in Fig. 1c . Further, we evaluated the additive effects of gangliosides (10, 50, and 100 lM) and aggregated Abs (10 lM of Ab1-40 or Ab1-42) on neurospheres. The addition of GM1 or GD3 gangliosides (50 or 100 lM) inhibited cell growth, with GD3 having greater effects than GM1 in a dose-dependent manner (data not shown).
Effects of Abs and Low Concentrations of Gangliosides on Embryonic NSCs
Recently, we reported that exogenously added Ab1-40 (10 lM) was incorporated into embryonic NSCs (monolayer culture), and the combination treatment with Ab1-40 (10 lM) and GM1 at 40 lM exerted cytotoxic effects on embryonic NSCs [22] . It is unclear, however, whether a lower concentration of gangliosides and Abs had similar effects on embryonic NSCs. To clarify this issue, we first examined the number of embryonic NSCs in monolayer culture after treatment with lower concentrations (1 nM to 10 lM) of gangliosides. GM1 or GM3 at lower concentrations (1 nM to 1 lM) significantly promoted cell proliferation for embryonic NSCs (Fig. 2) , but GD3 did not (data not shown). Next, we evaluated the combinatorial effects of Abs and low concentrations of gangliosides on cell proliferation of embryonic NSCs. Treatment with soluble Ab1-40 and GD3 (10 nM to 10 lM) had inhibitory effects for embryonic NSC proliferation (Fig. 3a) , but GM1 and GM3 had no effects (data not shown). Soluble Ab1-42 (10 lM) alone exerted a dramatic stimulatory effect on cell proliferation of embryonic NSC monolayer culture and the number of NSCs increased dramatically (149 ± 10 %) (Fig. 3b) . Figure 3b also shows that addition of GM1 and GD3 enhanced proliferative effects of soluble Ab1-42 on embryonic NSCs, whereas GM3 had no additional effects (data not shown). Similar to neurosphere preparations, the numbers of embryonic NSCs grown as monolayer cultures also increased after treatment with aggregated Ab1-40 or Ab1-42 (Figs. 1c, 4) . As shown in Fig. 4b , treatment of cells with 100 nM of GM1 significantly increased the cell number on embryonic NSCs treated with aggregated Ab1-42. GM3, however, exerted inhibitory effects on aggregated Ab-stimulated cell proliferation (Fig. 4a, b ). Similar to neurospheres (Fig. 1c) , the number of cells was slightly decreased in monolayer culture of embryonic NSCs treated with both soluble and aggregated forms of Ab25-35 (data not shown). Figure 5 shows the percentage of apoptotic embryonic NSCs after treatment with soluble and aggregated forms of Abs (1-40 and 1-42). No difference was found in the number of cells between NSCs treated with and without soluble forms of Abs. This result was consistent with our previous report that expression of active caspase-3 had no difference between intact cells and NSCs treated with soluble form of Ab1-40 [22] . Taken together, our data suggest that the increase of cell number with soluble Ab1-42 treatment may cause cell proliferation rather than protection from cell death. In contrast, the number of NSCs undergoing apoptosis decreased significantly by treatment with the aggregated Those results are also consistent with our previous observations [22] that the combined treatment with high concentrations of gangliosides and Abs exhibited enhanced apoptotic effects.
Apoptosis of NSCs Treated with Abs and Gangliosides
Discussion
Although Abs at elevated concentrations in brain are generally considered to be cytotoxic effect owing to their ability to form fibrils, there has been a growing awareness of the potential beneficial effects on neurogenesis of Abs at low concentrations. Those observations are, however, controversial as some reports also indicate that they are detrimental to neurogenesis. Some of the discrepancies could be traced to the use of different forms and concentrations of Abs, either in the presence or absence of gangliosides that bind with those peptides. For this reason, we first undertook this study with the goal of clarifying the effect of various forms of Abs on NSCs in different conditions using cell proliferation as a criterion. We found that soluble Ab1-42 and aggregated Abs (Ab1-40 and Ab1-42) stimulated cell proliferation in NSCs. This is consistent with several reports demonstrating the stimulatory effects of Abs on the proliferation of NSCs [13, 14, 16, 27] . Most remarkably, several in vivo studies also showed that intracerebroventricular infusion of Ab1-42 in nanomolar concentrations promotes neurogenesis in adult mouse brains [18] , and Ab accumulation increases neurogenesis in the hippocampus and other brain regions in AD transgenic mouse models [28] [29] [30] [31] [32] [33] . It is interesting to note that AD patient's brain revealed increased neuronal precursor markers, such as doublecortin and polysialylated neural cell adhesion molecule (PSA-NCAM) in the hippocampus, presumably in response to the shedding of Abs [31] . Our current study confirmed that both soluble and aggregated forms of Ab1-42 have proliferative effects on NSCs.
Ab1-40 and Ab1-42 are two major forms of Ab (Fig. 1a) , and during normal metabolism of amyloid precursor protein (APP), Ab1-40 is predominantly produced. The Ab1-42 species is usually a minor product, but is more cytotoxic and forms aggregates more easily than Ab1-40 [34] . Ab1-42 is the major peptide constituent of amyloid plaques, and increased production of the 42-amino acid peptide correlates with earlier onset of AD. Approximately 1 % of freshly dissolved Ab1-40 forms dimers [35] . However under the same conditions, about 7.4 % of Ab1-42 is converted to the dimeric form. Thus, it suggests that the soluble Ab1-42 has a higher tendency to exist as dimers. Ab1-42 has less configurational entropy and has been found to confer higher rigidity on the C terminus, which may explain the higher amylidogenic ability [36] . Yang and Teplow [37] reported that the two additional hydrophobic residues (isoleucine and alanine) in Ab1-42 contribute significantly to the contact between the C terminus and the central hydrophobic clusters. Thereby, the bsheet structure of Ab1-42 is more stable than Ab1-40. Those structural distinctions of between Ab1-40 and Ab1-42 might affect their biological activities such as their ability to contribute to NSC proliferation. The higher rigidity, less entropy and dimeric stability of Ab1-42 might increase its interaction with NSC membranes, which in turn, modulate its effect on cellular proliferation.
Significant changes in ganglioside patterns in AD brains have been reported. In AD patients brain, major gangliosides such as GM1, GD1a, GD1b and GT1b are all decreased [38] [39] [40] [41] [42] and b-series gangliosides such as GD1b and GT1b are preferentially affected. Additionally, in frontal and parietal cortex simple gangliosides, including GM2, GM3, GM4 and GD3, are elevated. These findings suggest that abnormal ganglioside metabolism coincides with the affected brain region of neurodegeneration in AD patients. However, we and others have not detected significant changes in the major brain ganglioside pattern in the AD mouse brains [43] [44] [45] except an increase of minor gangliosides such as GM2 and GM3 in the cerebral cortex [46] . Most interestingly, there is an increase of cholinergic neuronal marker gangliosides such as GT1aa and GQ1ba [43] . Since Abs have a tendency to bind gangliosides, we also examined the ability of gangliosides and combinations of gangliosides and Abs on cell proliferation. In this study, we found that lower concentrations of GM1 and GM3 promote cell proliferation on NSCs (Fig. 2) . Other investigators also reported that exogenously added gangliosides exhibited stimulatory effects on cellular proliferation of induced pluripotent stem [47] and vascular smooth muscle cells [48] . We have reported NSCs express GD3 as a predominant ganglioside [26, 49, 50] and it is co-localized with EGFR to regulate cellular proliferation induced by EGF (unpublished data). Quite contrarily, it has been reported that GD3 induces mitochondrial permeability transition and this event precedes apoptosis [51] , and GD3 is required for Fas-induced cell death and Ab-induced cell death [52, 53] . As mentioned in the Result section, treatment of NSCs with a high concentration of GD3 (50 lM) and Abs induced NSCs to undergo apoptosis ([50 %). Thus, the positive or negative effects of gangliosides might depend on culture conditions and ganglioside concentrations. Our results, together with those from other investigators, suggest that gangliosides modulate NSC proliferation or apoptosis depending on the concentrations of gangliosides and the culture conditions of the cells. With respect to Ab25-35, it does not occur naturally but has been shown to mimic the adverse effects of Ab1-42 in several studies [14] . Interestingly, hippocampal neuronal cultures treated with Ab25-35 showed enhanced metabolism of lipids such as phospholipids (?52 %) and gangliosides (?193 %) [54] . In addition, exposure of rat cultured cortical neurons to Ab25-35 induced a substantial increase of the intracellular GD3 levels [52] . Those reports suggest that Abs can modulate ganglioside metabolism in the NSCs and prompted us to propose that a combined use of Abs and gangliosides in suitable concentrations should promote NSC proliferation. We evaluated the number of embryonic NSCs treated with low concentrations of GM1 and GD3 in the presence of soluble forms of Abs. In embryonic NSC culture, lower concentrations of GD3, combined with soluble Ab1-40, had an inhibitory effect on cellular proliferation. On the other hand, lower concentrations of GM1 and GM3 with Ab1-42 enhanced proliferation of embryonic NSCs. GM1 also promoted cell proliferation with the aggregated form of Ab1-42. These results indicate that appropriate concentrations of both gangliosides and Abs are critically involved in stimulating NSC proliferation.
Abs is produced by cultured cells during normal cellular metabolism [55, 56] . Because Ab1-40 and Ab1-42 are present in the brain and cerebrospinal fluid of normal individuals, it suggests that these peptides are likely physiologically active in normal life [57] . Despite extensive efforts for studying Abs for their cytotoxic effects in AD, the normal biological functions and positive effects of Abs have remained elusive. Gangliosides are known to interact with Abs with high affinities and are known to be involved in conformational changes of Abs. In this study, we evaluated the effect of gangliosides, GM1, GD3 and GM3, and Abs (Ab1-40, Ab1-42, and Ab25-35) on cell proliferation of the NSCs. Aggregated Ab1-40 and soluble or aggregated Ab1-42 were involved in cell proliferation of the NSCs. The lower concentrations of gangliosides and Abs 1-42 induced cell proliferation of NSCs, suggesting that understanding the roles of gangliosides and Abs on NSCs may help devise new strategies for treatment of AD.
